Click here to go to the previous page
Retrospective cohort study of transfusion rates in cancer patients before and after implementation of the Medicare National Coverage Determination (NCD) restricting coverage for erythropoiesis-stimulating agents (ESAs)
Presenters will be at their boards to answer your questions 12:30 p.m. - 2:00 p.m.